Clinical implications of mast cell involvement in allergic conjunctivitis.

about

DS-70, a novel and potent α integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs

P2860

Q56362461-C966AD16-5432-4C1E-B78E-4A46801C4EB2

P2860

Clinical implications of mast cell involvement in allergic conjunctivitis.

Item

http://www.wikidata.org/entity/Q48361100

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical implications of mast cell involvement in allergic conjunctivitis.

@en

Clinical implications of mast cell involvement in allergic conjunctivitis.

@nl

type

Item

label

Clinical implications of mast cell involvement in allergic conjunctivitis.

@en

Clinical implications of mast cell involvement in allergic conjunctivitis.

@nl

prefLabel

Clinical implications of mast cell involvement in allergic conjunctivitis.

@en

Clinical implications of mast cell involvement in allergic conjunctivitis.

@nl

P1476

Clinical implications of mast cell involvement in allergic conjunctivitis.

@en

P2093

L Bielory

http://www.w3.org/2001/XMLSchema#string

T Rambasek

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions

Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management

Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures

Japanese guidelines for allergic conjunctival diseases 2017.

Conjunctivitis: a systematic review of diagnosis and treatment

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.

The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model.

Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.

Role of beta-chemokines in mast cell activation and type I hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies.

P304

528-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.13334

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

D Elieh Ali Komi

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29105783

http://www.w3.org/2001/XMLSchema#string

P921

mast cells

Clinical implications of mast cell involvement in allergic conjunctivitis.

about

P2860

P2860

Clinical implications of mast cell involvement in allergic conjunctivitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921